SAN DIEGO, CA--(MARKET WIRE)--Sep 12, 2007 -- Tulip BioMed™, Inc. (Other OTC:TPBD.PK - News), a developer of medical devices and patented technologies for the living tissues market, including plastic, cosmetic, and orthopedic surgeries, today announced that it has initiated a recapitalization of is equity and reorganization of certain debt instruments
